Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer’s disease

by

A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer’s disease.

Leave A Comment

Your email address will not be published. Required fields are marked *